HURA
Price
$2.81
Change
-$0.01 (-0.35%)
Updated
Jun 6 closing price
Capitalization
126.24M
INAB
Price
$4.17
Change
+$4.05 (+3375.00%)
Updated
Jun 6 closing price
Capitalization
329.77M
60 days until earnings call
Interact to see
Advertisement

HURA vs INAB

Header iconHURA vs INAB Comparison
Open Charts HURA vs INABBanner chart's image
TuHURA Biosciences
Price$2.81
Change-$0.01 (-0.35%)
Volume$70.89K
Capitalization126.24M
IN8bio
Price$4.17
Change+$4.05 (+3375.00%)
Volume$528.25K
Capitalization329.77M
HURA vs INAB Comparison Chart
Loading...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HURA vs. INAB commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HURA is a StrongBuy and INAB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (HURA: $3.21 vs. INAB: $0.14)
Brand notoriety: HURA and INAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HURA: 101% vs. INAB: 235%
Market capitalization -- HURA: $126.24M vs. INAB: $329.77M
HURA [@Biotechnology] is valued at $126.24M. INAB’s [@Biotechnology] market capitalization is $329.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HURA’s FA Score shows that 0 FA rating(s) are green whileINAB’s FA Score has 1 green FA rating(s).

  • HURA’s FA Score: 0 green, 5 red.
  • INAB’s FA Score: 1 green, 4 red.
According to our system of comparison, both HURA and INAB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HURA’s TA Score shows that 4 TA indicator(s) are bullish while INAB’s TA Score has 5 bullish TA indicator(s).

  • HURA’s TA Score: 4 bullish, 6 bearish.
  • INAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INAB is a better buy in the short-term than HURA.

Price Growth

HURA (@Biotechnology) experienced а -3.02% price change this week, while INAB (@Biotechnology) price change was +12.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

INAB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INAB($330M) has a higher market cap than HURA($126M). HURA YTD gains are higher at: -21.516 vs. INAB (-44.790). INAB has more cash in the bank: 11.1M vs. HURA (3.02M).
HURAINABHURA / INAB
Capitalization126M330M38%
EBITDAN/A-26.94M-
Gain YTD-21.516-44.79048%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash3.02M11.1M27%
Total DebtN/A5.03M-
FUNDAMENTALS RATINGS
HURA: Fundamental Ratings
HURA
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HURAINAB
RSI
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 11 days ago
81%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
MACD
ODDS (%)
Bearish Trend 11 days ago
82%
Bullish Trend 11 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend about 1 month ago
80%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 11 days ago
81%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been closely correlated with BIORQ. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if HURA jumps, then BIORQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
+9.18%
BIORQ - HURA
72%
Closely correlated
+10.81%
GNPX - HURA
60%
Loosely correlated
+3.28%
SNSE - HURA
48%
Loosely correlated
-4.53%
BIVI - HURA
46%
Loosely correlated
-0.95%
INAB - HURA
36%
Loosely correlated
-1.32%
More

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
-1.32%
IDYA - INAB
47%
Loosely correlated
+0.72%
SRZN - INAB
39%
Loosely correlated
+3.11%
HURA - INAB
36%
Loosely correlated
+9.18%
GRI - INAB
35%
Loosely correlated
+3.05%
SNSE - INAB
33%
Loosely correlated
-4.53%
More